ASFA 2011 Annual Meeting Presentations

The ASFA 2011 Annual Meeting was held at the Westin Kierland Resort & Spa in Scottsdale, AZ from June 1 - 4, 2011. Posted below are presentations that were delivered at the ASFA 2011 Annual Meeting (for which ASFA has the speaker's permission to make available for education and training purposes).

Please click here to download the ASFA 2011 Academic and Corporate Programs.

Disclaimer:
Reference to these materials will be useful but not comprehensive in developing appropriate standards of care. Their use does not confer any professional qualification or standard. Publication of these materials does not constitute an endorsement by ASFA. ASFA has not reviewed these materials to ensure consistency with acceptable practices. The views expressed in these materials represent the opinion of the authors. ASFA expressly disclaims any liability arising from any inaccuracy or misstatement. Each facility and/or individual referring to these materials should analyze the information, practices, and procedures outlined therein to determine their acceptability for use in the context of their own obligations and within their own facility's standards and procedures.

Wednesday, June 1, 2011

Apheresis Review Session

Apheresis Instrumentation
Dobri Kiprov, MD, HP(ASCP)

Review of Clinical Applications in Apheresis Part 1
Review of Clinical Applications in Apheresis Part 2
Joseph Schwartz, MD and Anand Padmanabhan Md, PhD


Donor Eligibility – the Who, What, When, Where and Why

Matthew D. Coleman, MD

Donor and Patient Care
Regina Rohe, RN, BSN, HP(ASCP)

Access Issues

Salil Joshi, MD

Regulatory Considerations

Theresa Stec, BA, MT(ASCP)

Plasmapheresis and Pediatric Extracorporeal Membrane Oxygenation

Edward. C.C. Wong, MD

Graduate Medical Education Forum

Overview of Apheresis Physicians Committee
Nicole Zantek, MD, PhD

e-Learning Resources for Apheresis and Transfusion Medicine

Sara Koenig, MD

Simulation Teaching – Pros and Cons

Mojca Remskar Konia, MD, PhD

Apheresis Medicine: The Instrumentation Workshop

Gay Wehrli, MD

The ASFA Network (Committee Deliberations)

Carol S. Marshall, MD

Thursday, June 2, 2011

Opening Combined Symposium – Donor and Stem Cell Collection

Adverse Events in HPC Collections
Jeffrey Winters, MD

Platelet Additive Solutions
Joseph Sweeney, MD

The Evolving Roles of Apheresis and Transfusion Medicine in Cellular Therapies
Don Siegel, MD, PhD

Licensure of Stem Cell Products

Ellen Lazarus, MD

Francis S. Morrison, MD Memorial Lecture

Donor Safety: Vasovagal Reactions, Relative Hypovolemia and The Band Aid Hypothesis

Ronald Gilcher, MD

Plenary Abstract Session

Morbid Obesity is an Adverse Risk Factor for Autologous Peripheral Blood Hematopoietic Progenitor Cell Collection

Laura Cooling, MD, MSC

Magnesium Supplementation during Pediatric Apheresis Procedures
Fay West, MD

Offline Photopheresis Effectively Results in Apoptosis And Inhibition Of Lymphocyte Proliferation
Katherine Radwanski, MS

Improved Survival of Children with Sickle Cell Anemia and Stroke who Continue Blood Transfusion after Transition into an Adult Program

Samir Ballas, MD

High- Dose Cytarabine fro Mobilization and Collection of Autologous Hematopoietic Progenitor Cells

Laura Cooling, MD, MSC

Quality Assessment of Apheresis Platelets Stored in Intersol

Linda Kline, MT

Management of Systemic Unfractionated Heparin Anticoagulation during Therapeutic Plasma Exchange
Grace A.B. Totoe, MD

A phase I Healthy Volunteer Exploratory Study to Assess Induction of Apoptosis Associated with the Therokos UVAR XTS System

Christine Burnett

Comparison of Bacterial Detection Rates and Septic Reactions for Apheresis Platelets versus Prestorage Pooled WB- Derived Platelets

Anne Eder, MD, PhD

Education Session I: Basic Donor Apheresis

Guess Who’s Coming to Inspect? A Guide to Preparing Your Staff - Part 1

Guess Who’s Coming to Inspect? A Guide to Preparing Your Staff - Part 2

Wanda Koetz, RN, HP(ASCP) and Theresa Stec, BA, MT(ASCP)

Safety Initiatives for High School Blood Donors

Anne Eder, MD, PhD

Donor Conversion and Maximizing Automated Collections

Antonia Hagen - Coonradt

Education Session II: Basic Therapeutic Apheresis

TPE in Renal Disease
Vishesh Chhibber, MD

Fistula Care -Part 1
Dawn Rathburn, RN, HP

Friday, June 3 2011

Scientific Symposium

Management of Patients with Very High Cholesterol

Joyce Ross, MSN, CRNP, CLS, FNLC, FPCNA

LDL Apheresis using Destrous Sulfate Absorption and Heparin Precipitation

Patrick Moriarty, MD

Sickle Cell Disease- Pathophysiology and Clinical Presentation

Ravindra Sarode, MD

Treatment of Sickle Cell Disease: Simples vs. Exchange Transfusion

Sally Campbell- Lee, MD

Education Session III: Cellular Therapy

A Day in Apheresis, The Moffitt Cancer Center Experience

Darlene Rahn, BS, MT, HP(ASCP)

Collection of Peripheral Blood Stem Cells, MNC Collection, and the Goals of Getting the Proper Cells with Different Instruments

Edwin Burgstaler, MT, HP(ASCP)

Education Session IV: Advanced Therapeutic Apheresis

Fistula Care – Part 2: Troubleshooting

Dawn Rathburn, RN, HP

Special Considerations for Apheresis in Renal Patients

Rasheed Balogun, MD

Abstract Session I: Therapeutic Apheresis

A Case of Chronic Thrombotic Thrombocytopenic Purpura-Maintaining Balance between Inventory and Patient Quality of Life
Tisha M. Foster, MD

Explosive Diarrhea as a Novel Complication of Therapeutic Plasma Exchange (TPE) in Patients Treated for Recurrent Focal Segmental Glomerulosclerosis (FSGS)
Phillip J. DeChristopher, MD, PhD

Thrombocytapheresis for Post-Splenectomy Rebound Thrombocytosis in a Patient with Chronic Immune Thrombocytopenic Purpura on Romiplostim

Gina Dargo, RN

ADAMTS13 Distinguishes Thrombotic Thrombocytopenic Purpura (TTP) from Other Forms of Thrombotic Microangiopathies (TMA)

Neil, Shah, MD

Longitudinal Characterization of ADAMTS13 Activity and Antibody Profiles in Thrombotic Thrombocytopenic Purpura Arising in a Background of Systemic Lupus Erythematosus

Elizabeth Biller, MD

Novel ADAMTS13 Mutations in an Obstetric Patient with Upshaw-Schulman Syndrome

Taylor Deal, MD

Routine Prophylactic Intravenous Calcium Supplementation to Prevent Citrate Reactions during Plasma Exchange is Not Indicated

Nicole De Simone

The Potential Role of Plasma Exchange as a Treatment for Bilateral Diffuse Uveal Melanocytic Proliferation: a Report for Two Cases

Elizabeth Jaben, MD

Successful Treatment with Therapeutic Plasma Exchange in a Patient with Advanced Exudative Retinopathy Due to Poorly Controlled Hypertriglyceridemia

Brian Poirier, MD

Antibody Mediated Rejection Post Renal Transplantation: Balancing the Adverse Effects of daily Plasma Exchange with DSA Reduction

Ashok Tholpady, MD, MSPH

Plasma and RBC Exchange for Erythropoietic Protoporphyria

Monica B. Pagano, MD

Abstract Session II: Cellular Therapy and Miscellaneous

Harvesting Stem Cells from a Challenging Patient with Beta Thalassemia Mobilized with Plerixafor (Mozobil)

Jennifer Anderson, RN, HP(ASCP)

Initial Single-Center Experience of Optia WBC Version 5 Software in Routine Clinical Use in 24 Consecutive Autologous PBSC Collections, Compared with a Control Group of 24 Procedures using the Cobe Spectra MNC Setting

Kenneth Kouglas, MD

PBCD34 Collection Trigger for Poorly Mobilized Patients

Jacquelyn Choate, MD

The Use of Plerixafor in Hematopoietic Stem Cell Collections of Pediatric and Adult Patients-A Single Center Experience

Huy Phu Pham, MC

The Safety of a Stem Cell Collection in a Patient with Neuroblastoma Complicated by a Thrombus

Grace Cruz Banez-Sese, MD

Analysis Comparing Standard Photopheresis (SP) and Modified Photopheresis (MP)

Teresita T. Bernardo, BSN, RN, HP(ASCP)

A One- Year Assessment of Quality Indicators within an Apheresis- Only Center Operated by a Large Dialysis Provider

Victoria Chapman, RN, HP(ASCP)

Manual Blood Volume Calculation Versus Nadler’s Formula for Therapeutic Apheresis Procedures

Annabelle Chua, MD

Abstract Session III: Therapeutic Apheresis

Rapid Increases in Parasitemia following Red Cell Exchange for Malaria

Phandee Watanaboonyongcharoen, MD

Chronic Red Blood Cell Exchange in Patients with Iron Overload

Robin Wills, RN, HP, BSN

Comprehensive Review of Sickle Cell Disease Patients on Chronic Exchange Transfusion Therapy Improves Patients Management

Poulomi Jeevan Pai, MD

A Restrospective Analysis of the Performance of the 2003 and 2010 American Society for Apheresis Guidelines at a Community Hospital: A Ten Year Experience

Craig Emmitt Cole, MD

Routine Coagulation Results Do Not Correlate with Pre-Procedure Fibrinogen in Patients Receiving Plasma Exchange with Albumin Replacement Fluid

Yen-Michael Hsu, MD, PhD

Evaluation of Fibrinogen Levels in Patients with Acute cardiac Transplant Rejection who Receive Daily Therapeutic Plasma Exchange

Caitlin Halverson, MD

Is Plasma Free hemoglobin a Legitimate Target for Therapeutic Plasma Exchange?

Jay S. Raval, MD

Abstract Session IV: Donor Apheresis

Performance of the Platelet PGD Test for the Detection of Bacterial Contamination of Apheresis Platelets: A Single Center Experience

Nicole Zantek, MD, PhD

Pilot Program using Trima Accel to Reduce Allogenic Platelet usage During Cardiac Surgery

Melissa Alberts, CCP, LP

Implementing Intersol Platelet Additive Solution

Nancy Meyer

Does Seasonality Influence Adverse Donor Events in Automated Donors?

Richard Gammon, MD

Decrease in the Difference between Instrument Predicted Platelet Count and Actual Platelet Count Following Platelet Collection after Software Upgrade

Manish Gandhi, MD

An Inconvenient Forgetfulness

Richard Gammon, MD

Pseudothrombocytopenia in a Platelet Donor

Joanne Becker, MD

Education Session V: Advanced Donor Apheresis

Implementing Vista at a Multi-site Blood Center

Hannah Acevedo, MS, MT(ASCP), SBB

Analyzing Apheresis Collection Data to Optimize Performance-A success Story

Tanya Ferber, RN

Education Session VI: Management Issues

Conflict Management Using Performance Management

Mary L. Foss

Procedures Less Often Done-Maintaining Competency

Christina Anderson, RN, BSN, HP(ASCP)

Saturday, June 4, 2011

Closing Combined Symposium: Apheresis in Renal Diseases

Therapeutic Apheresis for Severe Vasculitis – Focus on Science vs. Treatment

David Jayne, MD, FRCP

Therapeutic Plasma Exchange for Multiple Myeloma – Pros

Nelson Leung, MD

Therapeutic Plasma Exchange for Multiple Myeloma – Cons

William F. Clark, MD, FRCPC, FACP, FASN

Therapeutic Plasma Exchange in Renal Transplantation – Mayo Clinic Approach

Jeffrey Winters, MD

Therapeutic Plasma Exchange in Renal Transplantation – John Hopkins Approach

Christopher Simpkins, MD, MPH

Education Session VII: Pediatric Apheresis

Family Feud: What’s the Deal with Therapeutic Apheresis in Kids Less Than 20kg?

Wendy Paul, MD

Pediatric Access

Salil Joshi, MD

Stem Cell Collection in the Pediatric Patient

Robin Wills, RN BSN HP(ASCP)

Education Session VIII: Apheresis Operations

Donor Apheresis Collections Personnel – Staffing Requirements and Challenges

Lee Clough, BSN, RN, HP(ASCP)

Patient Therapeutic Apheresis Personnel – Staffing Requirements and Challenges

Deanna Duvall, RN, BSN, HP(ASCP)

Physician Oversight of and Apheresis Program – MD Training, Management and Credentials

Chester Andrzejewski, MD, PhD, FCAP

This website is supported by an unrestricted educational grant provided by:

CaridianBCT